COMMUNIQUÉS West-GlobeNewswire

RedHill Biopharma to Present Positive Phase II Results of BEKINDA® for IBS-D at Digestive Disease Week 2018
30/05/2018
TEL-AVIV, Israel and RALEIGH, N.C., May 30, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
PolarityTE to Present at the Jefferies 2018 Global Healthcare Conference
30/05/2018
SALT LAKE CITY, May 30, 2018 (GLOBE NEWSWIRE) -- PolarityTE™, Inc. (Nasdaq: COOL ) today announced it will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 2:30pm ET. Denver M. [...]
Selecta Biosciences to Present at the Jefferies Global Healthcare Conference on June 06, 2018
30/05/2018
WATERTOWN, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB ), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]
BeyondSpring Announces $20 Million Registered Direct Offering
30/05/2018
NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ) (“BeyondSpring”), a global, clinical-stage biopharmaceutical company focused on the development and commercialization of innovative cancer [...]
Bellicum Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference
30/05/2018
HOUSTON, May 30, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Aclaris Therapeutics Announces Issuance of Additional Orange Book Listable Patent Covering ESKATA
30/05/2018
Issuance of U.S. Patent No. 9,980,983 Further Strengthens Aclaris’ ESKATA™ Patent Portfolio WAYNE, Pa., May 30, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical [...]
Zafgen, Inc. Expands Executive Leadership Team with Appointment of Brian McVeigh as Chief Business Officer
30/05/2018
BOSTON, May 30, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc., (Nasdaq: ZFGN ), a clinical-stage biopharmaceutical company using its proprietary knowledge of MetAP2 systems biology to help patients affected by a range of [...]
Antares Pharma Announces Receipt of Third Installment From Sale of ZOMAJET™ Needle-Free Delivery System
30/05/2018
EWING, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) (“Antares”) (“The Company”) today announced that it has received $4.75 million from Ferring Pharmaceuticals (“Ferring”) in connection [...]
ContraFect to Present New Data on CF-301 (exebacase) and Lysins Targeting Gram-Negative Pathogens at ASM Microbe 2018
30/05/2018
YONKERS, N.Y., May 30, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX ), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]
International Stem Cell Corporation Published Technology for Cartilage Generation in Journal of Tissue Engineering and Regenerative Medicine Technology
30/05/2018
CARLSBAD, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]
Microbot Medical Inc. Schedules its Periodical Townhall Meeting for Monday, June 4th at 9:00 a.m., Eastern Time
30/05/2018
HINGHAM, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT ), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]
AnaptysBio to Present at the Jefferies 2018 Global Healthcare Conference
30/05/2018
SAN DIEGO, May 30, 2018 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB ), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, [...]
Avivagen Announces Approval of OxC-beta™ For Use in Livestock in New Zealand
30/05/2018
OTTAWA, May 30, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and [...]
iKang Schedules 2017 Unaudited Fourth Quarter and Fiscal Year Earnings Release on June 21, 2018
30/05/2018
BEIJING, May 30, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG ), major provider in China’s fast growing private preventive healthcare services market, today announced [...]
OraSure Technologies to Present at Jefferies Global Healthcare Conference
30/05/2018
BETHLEHEM, Pa., May 30, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, President [...]
Affimed to Present at the Jefferies Global Healthcare Conference
30/05/2018
Heidelberg, Germany, May 30, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi [...]
Wake Radiology Launches EnvoyAI Platform in First-of-Kind Implementation
30/05/2018
RALEIGH, N.C., May 30, 2018 (GLOBE NEWSWIRE) -- Artificial intelligence platform provider, EnvoyAI TM ( www.envoyai.com ), recently completed their first successful customer installation at Wake Radiology ( www.wakerad. [...]
Helsinn Group and MEI Pharma Announce Upcoming Presentation at ASCO 2018 on the design of the Phase III PRIMULA study of Pracinostat in combination with azacitidine for the treatment of Acute Myeloid Leukemia (AML) in adult patients unfit f
30/05/2018
Helsinn Group and MEI Pharma Announce Upcoming Presentation at ASCO 2018 on the design of the Phase III PRIMULA study of Pracinostat in combination with azacitidine for the treatment of Acute Myeloid Leukemia (AML) in [...]
Herantis Pharma's Manager's Transactions
30/05/2018
Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 30 May 2018 at 9:30 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]

Pages